57 related articles for article (PubMed ID: 10354694)
1. [Clinical evaluation of 12 week salmeterol therapy in allergic asthma patients].
Siergiejko Z; Zietkowski Z; Rogalewska A; Chyrek-Borowska S
Pneumonol Alergol Pol; 1998; 66(9-10):450-5. PubMed ID: 10354694
[TBL] [Abstract][Full Text] [Related]
2. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
Busse WW; Casale TB; Murray JJ; Petrocella V; Cox F; Rickard K
Am J Manag Care; 1998 Nov; 4(11):1579-87. PubMed ID: 10338904
[TBL] [Abstract][Full Text] [Related]
4. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma.
Bateman ED; Kornmann O; Schmidt P; Pivovarova A; Engel M; Fabbri LM
J Allergy Clin Immunol; 2011 Aug; 128(2):315-22. PubMed ID: 21807250
[TBL] [Abstract][Full Text] [Related]
5. [Salmeterol improves control in asthmatic patients treated in general practice. A comparative study of salmeterol (Serevent) and salbutamol (Ventoline) in patients with mild to moderate asthma].
Staehr P; Vestbo I
Ugeskr Laeger; 1995 Jan; 157(1):36-40. PubMed ID: 7839545
[TBL] [Abstract][Full Text] [Related]
6. [The effect of salmeterol on specific and non-specific bronchial response in allergic asthma patients].
Siergiejko Z
Pneumonol Alergol Pol; 1998; 66(9-10):440-9. PubMed ID: 10354693
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of salmeterol (50 microgram) and fluticasone (250 microgram) in a single inhaler device (diskus) in patients with mild to moderate asthma].
Beeh KM; Beier J; Kornmann O; Wiewrodt R; Buhl R;
Pneumologie; 2002 Feb; 56(2):91-7. PubMed ID: 11842346
[TBL] [Abstract][Full Text] [Related]
8. Salmeterol xinafoate in children on high dose inhaled steroids.
Russell G; Williams DA; Weller P; Price JF
Ann Allergy Asthma Immunol; 1995 Nov; 75(5):423-8. PubMed ID: 7583864
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of combined therapy efficacy with disodium cromoglycate and salmeterol in children with atopic bronchial asthma].
Hofman J; Swiebocka E
Pol Merkur Lekarski; 1997 Oct; 3(16):168-70. PubMed ID: 9461722
[TBL] [Abstract][Full Text] [Related]
10. Comparison of high-dose salmeterol/fluticasone and moderate-dose salmeterol/fluticasone plus low-dose mometasone in patients with severe persistent asthma.
Kurashima K; Kagiyama N; Takayanagi N; Sugita Y
Respirology; 2011 Jul; 16(5):784-9. PubMed ID: 21382132
[TBL] [Abstract][Full Text] [Related]
11. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
Pearlman DS
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):180-4. PubMed ID: 7648385
[TBL] [Abstract][Full Text] [Related]
12. Dose-response study of inhaled salmeterol in asthmatic patients with 24-hour spirometry and Holter monitoring.
Kemp JP; Bierman CW; Cocchetto DM
Ann Allergy; 1993 Apr; 70(4):316-22. PubMed ID: 8466097
[TBL] [Abstract][Full Text] [Related]
13. Salmeterol versus theophylline in the treatment of asthma.
Pollard SJ; Spector SL; Yancey SW; Cox FM; Emmett A
Ann Allergy Asthma Immunol; 1997 May; 78(5):457-64. PubMed ID: 9164358
[TBL] [Abstract][Full Text] [Related]
14. Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma.
Wolfe J; Kreitzer S; Chervinsky P; Lawrence M; Wang Y; Reilly D; Davis S; Stahl E
Ann Allergy Asthma Immunol; 2000 Mar; 84(3):334-40. PubMed ID: 10752919
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the clinical efficacy and the safety of salmeterol/fluticasone propionate accuhaler compared to budesonide turbuhalar in the control of adult asthma].
Zhong NS; Zheng JP; Cai BQ; Xie CM; Sun TY; Wang DQ; Lin YP; Chen BY; Tao JJ; Kang J; Li Q; Xu YP; Zhou X; Guo XJ; Chen XD; Yin KS; Zhang DP; Zhou JY; Shen HH; Qiu C; Feng YL; Xiao BR
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):233-7. PubMed ID: 15854431
[TBL] [Abstract][Full Text] [Related]
16. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
[TBL] [Abstract][Full Text] [Related]
17. [Salmeterol improves the control of disease in patients with moderate asthma. A comparative study of inhaled salmeterol 50 mg and salbutamol depot tablets 8 mg, both administered twice daily].
Ringbaek TJ; Søes-Petersen U; Christensen M; Iversen ET; Rasmussen FV
Ugeskr Laeger; 1996 Jul; 158(27):3940-3. PubMed ID: 8701511
[TBL] [Abstract][Full Text] [Related]
18. [Treatment with salmeterol and quality of life in patients with asthma].
Wrońska J; Chazan R; Mazurek J; Droszcz W
Pneumonol Alergol Pol; 1998; 66(3-4):193-7. PubMed ID: 9857664
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma.
Weinstein SF; Pearlman DS; Bronsky EA; Byrne A; Arledge T; Liddle R; Stahl E
Ann Allergy Asthma Immunol; 1998 Jul; 81(1):51-8. PubMed ID: 9690573
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
